These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 33817720)
21. Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy. Hamias R; Volvich L; Paran E; Sion-Vardi N; Novack V; Szendro G; Greenberg G; Rudich A; Wolak T Curr Vasc Pharmacol; 2016; 14(3):288-94. PubMed ID: 26321081 [TBL] [Abstract][Full Text] [Related]
22. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. Kadoglou NP; Gerasimidis T; Kapelouzou A; Moumtzouoglou A; Avgerinos ED; Kakisis JD; Karayannacos PE; Liapis CD Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):258-65. PubMed ID: 20004120 [TBL] [Abstract][Full Text] [Related]
23. Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries. Kuzan A; Chwiłkowska A; Maksymowicz K; Abramczyk U; Gamian A Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672202 [TBL] [Abstract][Full Text] [Related]
24. Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. Stępień E; Wypasek E; Stopyra K; Konieczyńska M; Przybyło M; Pasowicz M Clin Biochem; 2011 Jul; 44(10-11):826-31. PubMed ID: 21539822 [TBL] [Abstract][Full Text] [Related]
25. Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque. Kosowski M; Basiak M; Hachuła M; Okopień B Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888688 [TBL] [Abstract][Full Text] [Related]
26. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. Asanuma YF; Shimada Y; Kouzu N; Yokota K; Nakajima K; Sato K; Akiyama Y; Isozaki M; Mikami AS; Kobayashi H; Mimura T Mod Rheumatol; 2013 Mar; 23(2):269-75. PubMed ID: 22584471 [TBL] [Abstract][Full Text] [Related]
27. Relationship between Calcification and Vulnerability of the Carotid Plaques. Pini R; Faggioli G; Fittipaldi S; Vasuri F; Longhi M; Gallitto E; Pasquinelli G; Gargiulo M; Stella A Ann Vasc Surg; 2017 Oct; 44():336-342. PubMed ID: 28479433 [TBL] [Abstract][Full Text] [Related]
28. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. Hakimi M; Hyhlik-Dürr A; von Au A; Betz M; Demirel S; Dihlmann S; Böckler D; Gross-Weissmann ML Int J Mol Med; 2013 Aug; 32(2):331-8. PubMed ID: 23722820 [TBL] [Abstract][Full Text] [Related]
30. Associations of local release of inflammatory biomarkers during carotid artery stenting with plaque echogenicity and calcification. Abe Y; Sakaguchi M; Furukado S; Okazaki S; Fujinaka T; Sakoda S; Yoshimine T; Kitagawa K Cerebrovasc Dis; 2010; 30(4):402-9. PubMed ID: 20720409 [TBL] [Abstract][Full Text] [Related]
31. Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. Martinetti A; Bajetta E; Ferrari L; Zilembo N; Seregni E; Del Vecchio M; Longarini R; La Torre I; Toffolatti L; Paleari D; Bombardieri E Endocr Relat Cancer; 2004 Dec; 11(4):771-9. PubMed ID: 15613451 [TBL] [Abstract][Full Text] [Related]
32. Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women. Albu A; Bondor CI; Crăciun AM; Fodor D Adv Med Sci; 2014 Sep; 59(2):293-8. PubMed ID: 25240503 [TBL] [Abstract][Full Text] [Related]
33. Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases. Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Ko YL Biomark Med; 2019 Jun; 13(9):751-760. PubMed ID: 31157557 [No Abstract] [Full Text] [Related]
34. Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis. Ramirez-Sandoval JC; Casanova I; Villar A; Gomez FE; Cruz C; Correa-Rotter R Perit Dial Int; 2016; 36(3):262-8. PubMed ID: 26293840 [TBL] [Abstract][Full Text] [Related]
35. Biomarkers of vascular calcification and mortality in patients with ESRD. Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076 [TBL] [Abstract][Full Text] [Related]
36. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke. Carbone F; Vuilleumier N; Burger F; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Mach F; Fainardi E; Montecucco F Eur J Clin Invest; 2015 Jun; 45(6):579-86. PubMed ID: 25845543 [TBL] [Abstract][Full Text] [Related]
37. A systemic review into carotid plaque features as predictors of restenosis after carotid endarterectomy. Zhou F; Hua Y; Ji X; Jia L J Vasc Surg; 2021 Jun; 73(6):2179-2188.e4. PubMed ID: 33253876 [TBL] [Abstract][Full Text] [Related]
38. Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population. Biscetti F; Tinelli G; Rando MM; Nardella E; Cecchini AL; Angelini F; Straface G; Filipponi M; Arena V; Pitocco D; Gasbarrini A; Massetti M; Flex A Cardiovasc Diabetol; 2021 May; 20(1):114. PubMed ID: 34044825 [TBL] [Abstract][Full Text] [Related]